Breaking News - Candlesense

First six months 2025: solid results and continued strategy delivery, highlighted by the launch of 313.7 MW Kelmė wind farm, the largest in the Baltics. Full-year 2025 Adjusted EBITDA and Investments guidance reiterated

AB “Ignitis grupė” publishes its First six months 2025 interim report, which is attached to this notice.

Is there any indication of changes in the company’s capital allocation plan (e.g., dividend policy, share buybacks, or further capex) in light of the reaffirmed guidance? How might the increased renewable capacity influence Ignitis Group’s exposure to carbon‑credit markets or ESG‑focused investor demand? What are the potential risks to the continued delivery of the 2025 strategy, such as regulatory changes, grid constraints, or construction delays on future projects?

Symbol: IGN

Earnings

27 days ago

Read more globenewswire

VEON Completes Sale of Beeline Kyrgyzstan

Dubai, August 13, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON”), announces that it has completed the sale of its 50.1% indirect stake in Sky Mobile LLC, operating under the Bee...

What is the anticipated reaction of institutional investors and analysts to this sale in terms of target price adjustments? How will the market interpret this move—as a strategic focus on core markets or a response to underperformance? Are there any contingent considerations or earn‑out provisions tied to the transaction that could affect future cash flows?

Symbol: VEON

Mergers

27 days ago

Read more globenewswire

Sampo plc’s share buybacks 12 August 2025

Sampo plc, stock exchange release, 13 August 2025 at 8:30 am EEST

Could the buyback program signal management's view on the company's growth prospects or undervaluation, and how should that be interpreted? What are the potential long‑term effects of the buyback on SAMPO's total share count and ownership structure? How might the buyback program influence SAMPO's dividend policy and future capital return strategy?

Symbol: SAMPO

Buybacks

27 days ago

Read more globenewswire

Sapiens to be acquired by Advent for $2.5 Billion

Sapiens shareholders to receive $43.50 per share in cash, a 64% premium to Sapiens' undisturbed closing share price of $26.52 on August 8, 2025 KEY HIGHLIGHTS Sapiens shareholders will receive $43....

How might institutional investors and existing shareholders react to the proposed acquisition? Are there any contingent considerations, earn‑outs, or post‑closing adjustments in the transaction? What regulatory approvals are required and what is the anticipated timeline for closing?

Symbol: SAPI

Mergers

27 days ago

Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye

Pratteln, Switzerland, 13 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distri...

Are there any contingent or performance‑based milestones tied to the agreement that could trigger future upside or downside for the company? How might this deal impact the stock's valuation multiples relative to peers in the rare‑disease and neuromuscular space? What are the potential risks associated with relying on a single local partner for distribution and promotion in Türkiye?

Symbol: SANN

Partnership

27 days ago

Read more globenewswire

Lerøy Seafood Group ASA: Invitation to presentation of results for Q2 and first half 2025

Lerøy Seafood Group ASA will present its results for Q2 2025 on 20 August 2025 at Scandic Flesland Airport hotel in Bergen at 08:45 CET during the event "Vestland på Børs". The presentation will be...

How might the Q2 results influence the valuation multiples (e.g., P/E, EV/EBITDA) that analysts are using for Lerøy Seafood? What is the outlook for Q3 2025 given the current market conditions and the company's operational plans? Did the company address any supply‑chain, regulatory, or environmental risks that could impact future quarters?

Symbol: LER

Earnings

27 days ago

Read more globenewswire

CareTrust REIT, Inc. Announces Pricing of Upsized Public Offering of Common Stock

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--CareTrust REIT, Inc. (NYSE: CTRE) (“CareTrust REIT” or the “Company”) announced the pricing of its upsized underwritten public offering of 20,000,000 shares o...

How should the offering be factored into technical analysis, such as support/resistance levels and volume‑weighted average price (VWAP) calculations? Could the capital raise trigger any changes in the REIT’s leverage ratios or credit ratings, and what are the implications for risk‑adjusted returns? What is the market’s perception of the pricing relative to the company’s recent trading range and valuation multiples (e.g., FFO‑price, NAV‑price)?

Symbol: CTRE

Equity offering

27 days ago

Comstock Prices $30 Million Upsized and Oversubscribed Public Offering of Common Stock

VIRGINIA CITY, Nev., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”), today announced that it has priced its previously announced underwritten public o...

How might the increased float and underwriting activity affect the stock's bid‑ask spread and trading volume in the coming weeks? What are the potential risks or upside scenarios associated with scaling industry‑level solar panel recycling facilities, and how might they influence the stock's long‑term valuation? What level of investor demand (oversubscription) was observed, and what does that indicate about market confidence in Comstock's growth strategy?

Symbol: LODE

Offering

27 days ago

Read more globenewswire

HGV Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

ORLANDO, Fla.--(BUSINESS WIRE)--HGV Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

What is the market’s reaction to the announcement (e.g., sentiment, analyst commentary) and how might it influence short‑term price movement? How might the combined offering and repurchase affect the company’s balance sheet, leverage ratios, and overall financial health? Will the share repurchase be conducted in the open market or through a tender offer, and what are the pricing mechanics?

Symbol: HGV

Offering

27 days ago

Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering

BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...

How might the market interpret the need for a $120 million raise—does it signal cash‑flow constraints, accelerated development plans, or strategic expansion? What potential impact could the warrant over‑hang have on the stock price if the warrants are exercised in the near term? Will the increased float from this offering improve liquidity and reduce bid‑ask spreads for CMPX shares?

Symbol: CMPX

Capital raise

27 days ago

Read more globenewswire